StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Sanofi Has Room for Higher Medivation (MDVN) Bid, Credit Suisse Says; Deal Could Be 7% Accretive in 2020 at $80
April 28, 2016 10:33 AM
Credit Suisse analyst Kennen MacKay weighs in on Medivation (NASDAQ: MDVN) after Sanofi launched a $52.50/share hostile bid. The ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Mergers and Acquisitions
Rumors
Next Articles
Medivation (MDVN) Affirms Receipt of $52.50/Share Takeover Offer from Sanofi (SNY); Will Review
April 28, 2016 9:13 AM
Medivation Confirms Receipt of Unsolicited Proposal From Sanofi
April 28, 2016 9:12 AM
Sanofi Offers to Acquire Medivation (MDVN) for $52.50/Share
April 28, 2016 6:14 AM
Sanofi : Sanofi Offers to Acquire Medivation for $52.50 Per Share in Cash
April 28, 2016 2:04 AM
